<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Nutr Metab</journal-id>
<journal-id journal-id-type="iso-abbrev">J Nutr Metab</journal-id>
<journal-id journal-id-type="publisher-id">JNME</journal-id>
<journal-title-group>
<journal-title>Journal of Nutrition and Metabolism</journal-title>
</journal-title-group>
<issn pub-type="ppub">2090-0724</issn>
<issn pub-type="epub">2090-0732</issn>
<publisher>
<publisher-name>Hindawi</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30687551</article-id>
<article-id pub-id-type="pmc">6327261</article-id>
<article-id pub-id-type="doi">10.1155/2018/4183407</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Nutritional and Pharmacological Effects on Oxidative Stress in Soft Tissue and Bone Remodeling</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Savasky</surname>
<given-names>Benjamin M.</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-1184-6784</contrib-id>
<name>
<surname>Mascotti</surname>
<given-names>David P.</given-names>
</name>
<email>dmascotti@jcu.edu</email>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Patel</surname>
<given-names>Naren</given-names>
</name>
<xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rodriguez-Collazo</surname>
<given-names>Edgardo</given-names>
</name>
<xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref>
</contrib>
</contrib-group>
<aff id="I1">
<sup>1</sup>University Hospitals, 27100 Chardon Rd., Richmond Heights, OH 4414, USA</aff>
<aff id="I2">
<sup>2</sup>John Carroll University, Department of Chemistry, 1 John Carroll Blvd., University Heights, OH 44118, USA</aff>
<aff id="I3">
<sup>3</sup>Foot and Ankle Specialists of Ohio, 7482 Center St. Suite #100, Mentor, OH 44060, USA</aff>
<aff id="I4">
<sup>4</sup>St. Joseph Hospital, Department of Surgery, 875 N. Dearborn St. #400, Chicago, IL 60610, USA</aff>
<author-notes>
<fn fn-type="other">
<p>Academic Editor: Michael B. Zemel</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>2018</volume>
<elocation-id>4183407</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>5</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Benjamin M. Savasky et al.</copyright-statement>
<copyright-year>2018</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Oxidative damage is the causal link to a multitude of pathologies, such as diabetes, arthritis, neuropathy, heart disease, and asthma. These conditions affect hundreds of millions of people nationwide, and billions worldwide. Even in otherwise healthy individuals, oxidative stress is a natural byproduct of metabolism that is augmented in “healthy” activities such as athletics. In many disease states, the pharmacological agents used to treat these conditions can induce oxidative damage and vitamin depletion. It is underappreciated by many that many of the most common medications prescribed result in oxidative stress. Therefore, physicians need to carefully scrutinize which medications their patients are on before surgery and treatment and during the recovery stage to obtain optimal healing results. We provide a review of the current literature of how oxidative damage and inflammation are linked to bone damage, Charcot neuroarthropathy, delayed wound healing, diabetic complications, and delayed flap consolidation. Where available, antioxidant intervention literature is offered to offset these conditions.</p>
</abstract>
<funding-group>
<award-group>
<funding-source>University Hospitals</funding-source>
</award-group>
<award-group>
<funding-source>John Carroll University</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>1. Background</title>
<sec id="sec1.1">
<title>1.1. General Oxidative Stress</title>
<p>Reactive oxygen species (ROS) consist of radical and nonradical chemical forms. Oxidative stress (OS) is present when ROS cannot be adequately balanced by the level of antioxidants. This imbalance can occur due to many factors including aging and hormonal changes, radiation exposure, certain drug therapies, certain diseases, and physiological events and an increase of metabolic activity/physical exercise [<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B3">3</xref>]. ROS are also produced during normal cellular metabolism following the activation of various enzymes such as NADPH oxidase, mitochondrial oxidases, and superoxide dismutase [<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>]. ROS levels are also pivotal to induce cell signaling which has a role in cell proliferation, differentiation, apoptosis, and inflammation [<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B6">6</xref>].</p>
<p>Three lines of defense are needed to protect cells from the damaging effects of OS: low molecular weight ROS scavengers, antioxidative enzymes, and proteases for proteolytic degradation of irreversibly damaged proteins. Some of these low molecular weight antioxidants are various vitamins and minerals, co-enzyme Q10 (CoQ10), thiol compounds such as glutathione (GSH), alpha-lipoic acid, <italic>N</italic>-acetyl cysteine, and polyphenols. The ratio of the reduced form of glutathione (GSH) to the oxidized form of glutathione (GSSG) is an important measure of oxidative stress [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>]. Further, GSH has the ability to positively influence the activity of certain transcription factors [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>] while other reduced thiol forms can act as antioxidant [<xref ref-type="bibr" rid="B11">11</xref>] scavengers and regenerate other antioxidants [<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>]. OS can also damage cell membranes and proteins which can decrease organ function and result in systemic events [<xref ref-type="bibr" rid="B13">13</xref>], resulting in nonunion bone fractures, delayed union bone fractures, poor skin viability, poor flap viability, and poor arterial viability. Therefore, understanding how the adverse effects of OS could be abolished by altering the nutritional status of patients is paramount.</p>
<p>A side effect of drug therapy, prescription and over the counter, is depletion of vitamins, minerals, and antioxidants [<xref ref-type="bibr" rid="B14">14</xref>]. Many of these depletions affect antioxidants directly, but all may influence overall physiology stressing antioxidant defenses. For instance, corticosteroids function to depress the immune response; however, it leads to increased OS [<xref ref-type="bibr" rid="B15">15</xref>]. This may be a function of depletion of melatonin, leading to sleep disruption, and depletion of selenium, which directly relates to glutathione peroxidase activity.</p>
<p>
<xref ref-type="table" rid="tab1">Table 1</xref> indicates the extent of micronutrient depletion that often accompanies both prescription and OTC medication ([<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>] and references in each). The effect of this depletion has many far-reaching effects, of particular interest to this study, delayed wound healing [<xref ref-type="bibr" rid="B18">18</xref>]. An often overlooked weapon in recovery from bone, wound, and surgical tissue damage is repletion of these micronutrients. Few products replete multiple depletions. One notable exception would be Red Ox+.</p>
<p>Herein, we provide a review of the role of oxidative damage in bone remodeling and wound healing, and micronutrient (especially antioxidant) adjunctive therapy and how this may positively affect limb lengthening and microsurgical reconstruction.</p>
</sec>
<sec id="sec1.2">
<title>1.2. Bone Remodeling</title>
<p>Current research demonstrates that oxidative stress can negatively impact bone remodeling [<xref ref-type="bibr" rid="B19">19</xref>–<xref ref-type="bibr" rid="B22">22</xref>]. Bone remodeling is a complex cycle, which lasts approximately 6 months, and harbors three main cells (osteoclasts, osteoblasts, and osteocytes), which under normal circumstances will be harmoniously regulated with the aid of cytokines, growth factors, and hormones. Oxidative stress activates the differentiation of pre-osteoclasts to adult osteoclasts while inducing apoptosis of osteoblasts and osteocytes and augmenting bone resorption [<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B21">21</xref>].</p>
<p>Oxidative stress has also been shown to upregulate RANKL and downregulate osteoprotegerin. Osteoprotegerin is a decoy receptor for the RANK by competing with RANKL. Osteoprotegerin is directly correlated with estrogen levels [<xref ref-type="bibr" rid="B23">23</xref>]. When estrogen levels are low, osteoprotegerin is also low which leads to increased bone resorption. RANKL binds to RANK, which triggers differentiation and activation of osteoclasts. This system is balanced by the relative expression of osteoprotegerin to RANKL, which are highly regulated by many factors including hormones, immune signals, and growth factors. An overexpression of RANKL can cause an overproduction and activation of osteoclasts as shown in primary cell culture from human samples as well as immortal cell line models [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B24">24</xref>].</p>
<p>Recent literature has displayed that osteocytes constitute 90% of the bone cell population and are essential for bone remodeling. Oxidative stress causes osteocyte apoptosis. These apoptotic osteocytes release sclerostin. Sclerostin is a protein that blocks bone formation by osteoblasts by binding to the Wnt co-receptors and low-density lipoprotein receptors (LRP) 4, 5, and 6 [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>]. This decreases the Wnt signaling pathway which, when active, stimulates osteoprotegerin [<xref ref-type="bibr" rid="B27">27</xref>–<xref ref-type="bibr" rid="B30">30</xref>]. Thus, the outcome of sclerostin upregulation of bone resorption is due, at least in part, by inhibiting the Wnt signaling pathway. Nitrogen bisphosphonates are widely used to control osteoporosis. However, they may contribute to increased OS, particularly when coupled with comorbidities such as diabetes mellitus (DM) and cancer [<xref ref-type="bibr" rid="B31">31</xref>]. Thus, the beneficial use of nitrogen bisphosphonates on bone density may also lead to potential negative side effects during high dose or long-term use in cases such as cancer treatment. In these cases, outcomes such as osteonecrosis and atypical long bone fractures have been observed [<xref ref-type="bibr" rid="B32">32</xref>]. This may be linked to the OS caused by the nitrogen bisphosphonates and/or their depletion of CoQ10. For instance, it has been found that nitrogen bisphosphonates, as well as statins, inhibit cellular synthesis of the antioxidant CoQ10 [<xref ref-type="bibr" rid="B33">33</xref>–<xref ref-type="bibr" rid="B35">35</xref>]. Nitrogen bisphosphonate use has also been shown to decrease serum antioxidant vitamin E and CoQ10 levels in postmenopausal women [<xref ref-type="bibr" rid="B35">35</xref>]. CoQ10 has been found to reverse spinal cord injury osteoporosis in rats by restoring bone mineral density and bone mineral content while increasing SOD [<xref ref-type="bibr" rid="B36">36</xref>]. CoQ10 was also shown to upregulate osteoblast-specific gene core-binding factor alpha 1 [<xref ref-type="bibr" rid="B36">36</xref>] and reduce osteoclastogenesis mediated through RANKL while also reducing inflammation in rheumatoid arthritic mice and augmenting the number of T-regulatory cells which directly decreases the number of T-helper 17 cells which are inflammatory [<xref ref-type="bibr" rid="B37">37</xref>]. T-regulatory cells are immunosuppressive and help maintain tolerance to self-antigens by preventing autoimmune diseases. Antioxidants, particularly CoQ10, would seem to be a protective adjunct therapy for each of the conditions outlined above.</p>
</sec>
<sec id="sec1.3">
<title>1.3. Wound Healing</title>
<p>Under normal circumstances, cells utilize glucose for energy via glycolysis which commences using the enzyme hexokinase. However, it has been long known that glucose challenge induces ROS production [<xref ref-type="bibr" rid="B38">38</xref>]. There are other fates of glucose such as the pentose phosphate pathway which is generally employed to generate NADPH reducing power and is able to create ribose-5-phosphate for nucleic acid synthesis (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
<p>Glucose may also react with aldose reductase in what is known as the polyol pathway to form sorbitol using NADPH as a reductant. Subsequently, the sorbitol is oxidized to fructose by catalysis with sorbitol dehydrogenase and production of NADH. This, in turn, slows glycolysis by inhibiting glyceraldehyde-3-dehydrogenase which prolongs the diversion of glucose away from glycolysis toward the polyol pathway [<xref ref-type="bibr" rid="B39">39</xref>]. Furthermore, the high NADH levels induce NADH oxidase activity which may form superoxide radicals as a byproduct [<xref ref-type="bibr" rid="B40">40</xref>]. When blood glucose is normal (about 100 mg/dl), aldose reductase has a low affinity for glucose which limits the polyol pathway utilization. However, in diabetics, particularly in chronically poorly controlled glucose patients, glucose levels saturate hexokinase (the first step in glycolysis) and the polyol pathway is engaged. In these chronic hyperglycemic conditions where the polyol pathway is active (<xref ref-type="fig" rid="fig1">Figure 1</xref>), there is a decrease in reduced NADPH which leads to decreased synthesis of reduced glutathione, nitric oxide, myo-inositol, and taurine, all of which are important for proper nerve function. Exacerbating this consumption of NADPH in diabetics is lower glucose-6-phosphate dehydrogenase (rate-limiting step in pentose phosphate pathway) activity which prevents NADPH from being produced as demonstrated in a rat model [<xref ref-type="bibr" rid="B41">41</xref>].</p>
<p>Reduced glutathione maintains glutathione peroxidase, vitamin C and E in their reduced forms, as well as facilitates proper DNA and protein synthesis [<xref ref-type="bibr" rid="B42">42</xref>] and has a vital function in iron metabolism. The decreased NADPH levels due to the polyol pathway compromise these vital reductive functions. Glutathione peroxidase is essential to limiting ROS. The increased sorbitol will augment the production of advanced glycation endproducts (AGEs), reducing kidney function and inducing an inflammatory response while increasing the hemoglobin A1C (HbA1c). This increase in ROS leads to leukocyte adhesion and immigration of inflammatory mediators into the wound bed [<xref ref-type="bibr" rid="B43">43</xref>], inhibits re-epithelialization [<xref ref-type="bibr" rid="B44">44</xref>], and favors a rich biofilm which may harbor anaerobic bacteria not found in culture [<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>]. Matrix metalloproteinases (MMPs) are capable of degrading extracellular matrix proteins, releasing apoptotic ligands and are increased in chronic wounds. They are regulated by tissue inhibitors of metalloproteinases. Gencer et al. showed that the expression of MMPs was increased in cells exposed to H<sub>2</sub>O<sub>2</sub>, and that removal of the oxidative stress decreased the expression of the MMPs [<xref ref-type="bibr" rid="B47">47</xref>]. Oxidized low-density lipoproteins were also shown to activate MMPs [<xref ref-type="bibr" rid="B48">48</xref>]. This appears to offer an intuitive intervention wherein topical antioxidants in conjunction with dietary or otherwise internal antioxidants could limit the amount of tissue damage from damage including surgical.</p>
<p>In a study by Dhall et al., they used the db/db diabetic mouse model of impaired healing and demonstrated that the diabetic mice were subject to chronic wounds with an abundance of free radicals. They then showed that they could reverse this chronicity with the antioxidants vitamin E and <italic>N</italic>-acetylcysteine by decreasing wound healing time, decreasing biofilm concentration, and increasing sensitivity to antibiotics while granulation tissue was formed with proper collagen deposition and remodeling [<xref ref-type="bibr" rid="B49">49</xref>]. In fact, diabetic mice, with OS, took over 100 days for their wounds to heal while wild-type mice without OS took on average 15 days for their wounds to heal [<xref ref-type="bibr" rid="B49">49</xref>]. When antioxidants were administered, the diabetic mice with OS took only 53 days on average for their wounds to heal [<xref ref-type="bibr" rid="B49">49</xref>]. Christman et al. showed that, for each 1.0% point increase in HbA1c, above 7.0%, the wound-area healing rate decreased by 0.028 cm<sup>2</sup>/day in humans with diabetes [<xref ref-type="bibr" rid="B50">50</xref>], and with the addition of antioxidants, the HbA1c was able to decrease [<xref ref-type="bibr" rid="B51">51</xref>]. The Akt pathway is a signal transduction pathway that promotes cell survival including cell proliferation, cell migration, and angiogenesis. In diabetics with elevated glucose and OS, Akt phosphorylation and gingival wound healing was shown to be impaired. When supplemented with <italic>N</italic>-acetyl-L-cysteine, Akt phosphorylation and gingival wound healing improved as did fibroblast proliferation and migration [<xref ref-type="bibr" rid="B52">52</xref>]. Toshiki et al. demonstrated in a rat model that they could significantly increase soft tissue wound healing in the mouth with application of CoQ10. They found that CoQ10 increased the expression of TIMP-1 and FGF while decreasing the expression of MMP-3 [<xref ref-type="bibr" rid="B53">53</xref>].</p>
<p>Prolonged OS can also produce psychological maladies including noncompliance and general compromised emotional status [<xref ref-type="bibr" rid="B54">54</xref>]. Oxidative damage may also be at the root of some of other psychological maladies such as autism [<xref ref-type="bibr" rid="B55">55</xref>]. Patient noncompliance such as not showing up for appointments, inconsistency in taking the medication, or not understanding the severity of their conditions may be due to these psychological OS-driven deficits.</p>
</sec>
<sec id="sec1.4">
<title>1.4. Charcot Neuroarthropathy</title>
<p>Charcot neuroarthropathy (CNA) is caused by an interaction between diabetes, neuropathy, and an inflammatory response [<xref ref-type="bibr" rid="B56">56</xref>] which results in bone lysis, mircobone damage, and bone deformity. The “French Theory” (neurovascular theory) suggests that CNA results from a damaged central nervous system which leads to uncontrolled blood flow and prolonged inflammation while the “Germanic Theory” suggests CNA results from trauma secondary to neuropathy which leads to inflammation.</p>
<p>In either case, OS causes the progression of inflammation eventually leading to bone lysis, microfracture, and bone deformity. AGEs are known to be augmented in CNA patients [<xref ref-type="bibr" rid="B57">57</xref>]. AGEs are produced during OS [<xref ref-type="bibr" rid="B58">58</xref>] and cause apoptosis of osteoblasts [<xref ref-type="bibr" rid="B59">59</xref>]. Receptor for advanced glycation endproducts (RAGE) is a transmembrane receptor that binds to AGEs and has been linked to number of neurodegenerative diseases such amyotrophic lateral sclerosis; Alzheimer's, Parkinson's, Huntington's, and Creutzfeldt-Jakob diseases; depression; and CNA [<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B61">61</xref>]. RAGE is known to increase the activity of RANKL leading to osteoclastogenesis in bone [<xref ref-type="bibr" rid="B62">62</xref>] and has been associated with atherosclerotic lesions and vascular calcification by increasing the expression of bone morphogenetic protein 4 in arteries [<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B64">64</xref>] and is thought to cause a phenotypic switch of VSMCs to an osteoblast-like phenotype [<xref ref-type="bibr" rid="B65">65</xref>]. This pathway is upregulated in CNA [<xref ref-type="bibr" rid="B66">66</xref>].</p>
<p>Vascular calcification (VC) is linked to CNA and is associated with OS [<xref ref-type="bibr" rid="B67">67</xref>]. VC is four times more likely to be present in diabetic patients then healthy subjects [<xref ref-type="bibr" rid="B68">68</xref>], and VC is a significant predictor of stroke, amputation, and myocardial infarction [<xref ref-type="bibr" rid="B69">69</xref>]. OS potentiates inflammation by augmenting tumor necrosis factor alpha (TNF-<italic>α</italic>), interleukin-6 (IL-6), and C-reactive protein [<xref ref-type="bibr" rid="B70">70</xref>]. CNA patients usually present with augmented serum inflammatory markers with a red hot swollen limb [<xref ref-type="bibr" rid="B71">71</xref>]. TNF-<italic>α</italic>, IL-6, and C-reactive protein have all been linked to VC [<xref ref-type="bibr" rid="B70">70</xref>] and nerve damage [<xref ref-type="bibr" rid="B72">72</xref>], indicting that VC and neuropathy are associated with inflammation. Diabetes is associated with an increase rate of lipoperoxidation [<xref ref-type="bibr" rid="B73">73</xref>], while VC is associated with an increased number of oxidized LDLs [<xref ref-type="bibr" rid="B74">74</xref>]. Excess mitochondrial ROS are also known to cause VC [<xref ref-type="bibr" rid="B29">29</xref>] and are the main cause of nerve damage in diabetics with good glucose control [<xref ref-type="bibr" rid="B75">75</xref>].</p>
<p>Brodeur et al. demonstrated that they could decrease calcification in the femoral artery of diabetic rats with the antioxidants: 4-hydroxy-tempol, alpha-lipoic acid, and apocynin. However, only apocynin significantly reduced femoral artery calcification [<xref ref-type="bibr" rid="B76">76</xref>]. Kim et al. found that alpha-lipoic acid significantly decreased aortic calcification in mice by inhibiting VSMC apoptosis by preserving mitochondrial function [<xref ref-type="bibr" rid="B77">77</xref>].</p>
<p>Related to the DM-induced CNA describe above, vitamin D has been shown by a number of methods to protect pancreatic beta cells from oxidative stress by inducing endogenous antioxidant pathways [<xref ref-type="bibr" rid="B78">78</xref>]. Therefore, drug-induced depletion of vitamin D would likely compromise pancreatic stress response.</p>
</sec>
<sec id="sec1.5">
<title>1.5. Flap Consolidation</title>
<p>Numerous studies have shown that oxidative stress can cause inflammatory changes causing decreased blood supply resulting in flap necrosis [<xref ref-type="bibr" rid="B79">79</xref>–<xref ref-type="bibr" rid="B81">81</xref>]. The increase in OS can cause ischemia reperfusion injury. Necrosis to the distal region of random flaps is a major problem. Ischemia reperfusion injury occurs when the reperfusion creates and harbors oxygen-derived free radicals which are deleterious to the tissues [<xref ref-type="bibr" rid="B82">82</xref>]. This is due to increased Fenton chemistry that accompanies reoxidation of iron [<xref ref-type="bibr" rid="B83">83</xref>]. Flaps in diabetics present their own risk as OS, an important factor in diabetes mellitus (DM) complications, is already significantly elevated in this population [<xref ref-type="bibr" rid="B58">58</xref>] and diminishes the microvascular supply resulting in necrosis [<xref ref-type="bibr" rid="B84">84</xref>]. DM also increases AGEs which damage tissue structure which decreases perfusion [<xref ref-type="bibr" rid="B85">85</xref>, <xref ref-type="bibr" rid="B86">86</xref>]. One important clinical feature of decreased perfusion, common in diabetics, would be erectile dysfunction (ED) [<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>]. Antioxidant therapy shows great promise in reversing or preventing ED concurrent with improved blood flow [<xref ref-type="bibr" rid="B89">89</xref>, <xref ref-type="bibr" rid="B90">90</xref>].</p>
<p>Calcitriol, a metabolite of vitamin D, is an antioxidant known that has many anti-inflammatory properties. In a random skin flap model, using rats, calcitriol was shown to increase SOD, thereby decreasing OS. This decrease in OS was shown to reduce inflammation and upregulate vascular endothelial growth factor in the flaps which significantly increased flap survival by decreasing edema and increasing angiogenesis [<xref ref-type="bibr" rid="B91">91</xref>]. Ufuk et al. showed that random flaps in DM mice exhibited greater OS and necrosis compared to controls while supplementing with long-term antioxidant vitamin E reduced OS and necrosis while increasing hyalinization of arterioles in the flaps [<xref ref-type="bibr" rid="B92">92</xref>]. In another study, aminoguanidine, an antioxidant which is known to halt AGEs, was given to DM rats before skin flaps were elevated. Aminoguanidine administration significantly increased flap viability in the diabetic rats by decreasing necrosis [<xref ref-type="bibr" rid="B93">93</xref>]. The antioxidants from grape seed extract (proanthocyanidin) and tomato extract (lycopene) were also shown to significantly decrease flap necrosis and inflammation when given two weeks before surgery and two weeks prior surgery [<xref ref-type="bibr" rid="B94">94</xref>] in rats. Naringin, the antioxidant found in citrus fruits, was found to significantly increase flap survival by increasing VEGF and SOD while decreasing TNF-<italic>α</italic> and IL-6 [<xref ref-type="bibr" rid="B95">95</xref>]. CoQ10 was also shown to significantly increase flap viability in rats while the highest serum level of CoQ10 was obtained with oral administration [<xref ref-type="bibr" rid="B96">96</xref>].</p>
</sec>
</sec>
<sec id="sec2">
<title>2. Discussion</title>
<p>Although antioxidants may not cure the root causes of the conditions explored above, many studies have shown that mitigation of the inflammatory products may allow for host recovery and more limited damage [<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B84">84</xref>, <xref ref-type="bibr" rid="B86">86</xref>, <xref ref-type="bibr" rid="B89">89</xref>, <xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B92">92</xref>–<xref ref-type="bibr" rid="B94">94</xref>, <xref ref-type="bibr" rid="B96">96</xref>]. Furthermore, starting patients on antioxidants prophylactically could prevent damage from starting. One example would be the vitamin D protection of pancreatic beta cells referred to above [<xref ref-type="bibr" rid="B78">78</xref>]. Others would be CoQ10 upregulating osteoblast activity in bone remodeling [<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>] or antioxidants improving mental disturbances such as autistic behavior, also referred to above [<xref ref-type="bibr" rid="B55">55</xref>].</p>
<p>The seven well-known signs of oxidative stress are increased fatigue, memory loss and/or brain fog, muscle and/or joint pain, wrinkles and grey hair, decreased eye sight, headaches and sensitivity to noise, and susceptibility to infections. However, we noted that there are many more signs and symptoms which start at the cellular level and are less obvious for a physician to diagnose such as increased inflammatory mediators resulting in Charcot neuroarthropathy, delayed wound healing, failed surgical outcomes, erectile dysfunction, and poor bone stock.</p>
<p>Physicians should start to examine the GSH/GSSG levels as this will give you a definitive way to quantify oxidative stress. Choosing organic foods and avoiding nicotine and toxic chemicals may prevent some exogenous radicals from entering our body. However, as we age, it is inevitable that the constant bombardment of these radicals, from even natural internal metabolic pathways, will cause a cumulative damage [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B83">83</xref>]. Many conditions are also fueled by OS, such as rheumatoid arthritis, osteoporosis, and heart disease. We have also referenced evidence that diabetics are subject to OS when increased levels of glucose will enter the polyol pathway [<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>]. However, we have yet to scrutinize why some individuals with well-controlled blood glucose levels and HbA1c's in the proper range develop neuropathy, Charcot neuroarthropathy, and chronic wounds while some uncontrolled diabetics never have complications. Perhaps, these patients already consume a diet low in oxidative additives, have fortunate genetics, or have some other unknown mechanism that reduces these radicals.</p>
<p>Even the healthiest athlete is subject to OS as exercise will augment the rate of metabolism as food is processed to provide energy at the cellular level. An inevitable side effect of metabolism is the production of ROS and “free radicals” that can damage DNA and other cellular constituents. This damage can lead to cancer, advanced aging, and as we have displayed and increased susceptibility of delayed wound healing and bone remodeling (stress fractures). Osteoporosis is seen daily, whether it is in the elderly, diabetic, postmenopausal female or a consequence of the female athlete triad; these patients are under extreme OS. Bisphosphonates (<xref ref-type="table" rid="tab1">Table 1</xref>) are usually given to counter osteoporosis but could be causing more harm by depleting calcium-magnesium, phosphorus, and Coq10 [<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>]. Further, starting these patients on steroids or NSAIDs might decrease the discomfort but will cause OS and could potentially make the condition worse. The classic diabetic patient is on a biguanide and or sulfonylurea which both inhibit CoQ10 (<xref ref-type="table" rid="tab1">Table 1</xref>) and have shown to cause neuropathy. Although the diabetes was the initial cause of the neuropathy, it may well be that the prolonged treatment causes enhanced OS leading to further neuropathy. Furthermore, the diabetic patient with many comorbidities is usually taking a statin, ACE inhibitor, beta-blocker, and perhaps an antibiotic for their chronic wound. All these drugs deplete important nutrients (<xref ref-type="table" rid="tab1">Table 1</xref>), potentiating the OS already present from the disease.</p>
<p>Hemodialysis is another process often associated with chronic diabetes patients that leads to loss of nutrients. Chronic kidney disease, as mentioned above, can be a result of the AGEs reducing kidney function. These hemodialysis patients are already at a disadvantage with the retention of toxins and rapid depletion of antioxidants during hemodialysis. According to Liakopoulos et al., the process of iron infusion, length of hemodialysis therapy, anemia, and the central venous catheter all augment OS [<xref ref-type="bibr" rid="B97">97</xref>]. Physicians commonly prescribe CoQ10 therapy for a common statin side effect but ignore other depletions such as vitamins B1, B6, B12, C, calcium, magnesium, phosphorus, potassium, zinc, beta-carotene, and folic acid (<xref ref-type="table" rid="tab1">Table 1</xref>). Clearly, with common situations such as this, single vitamin or electrolyte therapies would be insufficient. One would require a more robust formula of all the potential vitamins, electrolytes, and antioxidants to replete the patient such as Red Ox+. There are many more drugs that deplete important nutrients that induce OS. Clinicians need to examine the drugs their patients are on and supplement accordingly. This is especially important for the preoperative and postoperative patient as we have shown through many studies that ameliorating OS will aid in bone remodeling, wound and soft tissue healing, and arterial and muscle and soft tissue flap consolidation. The combination of vitamins, minerals, and antioxidants is an essential weapon clinicians should have in their arsenal that needs to be used on a regular basis.</p>
</sec>
<sec id="sec3">
<title>3. Conclusion</title>
<p>Oxidative stress is at the heart of a myriad of maladies. Antioxidants are depleted by many of the medications that were intended to solve these health issues. Robust antioxidants at therapeutic levels would be an excellent way to reverse these ill effects, whether caused by medication-related depletion or directly from the disease state. Doctors should note patient medication profiles and add appropriate supplements accordingly.</p>
<p>More clinical outcomes of antioxidant and vitamin therapy to offset the depletion caused by pharmaceutical intervention should be examined, particularly with respect to markers such as oxidative stress levels, bone density, surgical and wound healing rates, and complete blood cell counts, as well as neuropathy.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work was supported by the University Hospitals and John Carroll University.</p>
</ack>
<sec>
<title>Conflicts of Interest</title>
<p>BMS and DPM own a stake in Wire-2-WireLLC, makers of Red Ox+.</p>
</sec>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valko</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leibfritz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Moncol</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cronin</surname>
<given-names>M. T. D.</given-names>
</name>
<name>
<surname>Mazur</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Telser</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Free radicals and antioxidants in normal physiological functions and human disease</article-title>
<source/>
<italic toggle="yes">International Journal of Biochemistry &amp; Cell Biology</italic>
<year>2007</year>
<volume>39</volume>
<issue>1</issue>
<fpage>44</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1016/j.biocel.2006.07.001</pub-id>
<pub-id pub-id-type="other">2-s2.0-33749986298</pub-id>
<pub-id pub-id-type="pmid">16978905</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>B.-W.</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling</article-title>
<source/>
<italic toggle="yes">Cellular Signalling</italic>
<year>2012</year>
<volume>24</volume>
<issue>5</issue>
<fpage>981</fpage>
<lpage>990</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2012.01.008</pub-id>
<pub-id pub-id-type="other">2-s2.0-84857116578</pub-id>
<pub-id pub-id-type="pmid">22286106</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Moschen</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Kaser</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pines</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dotan</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Gut, inflammation and osteoporosis: basic and clinical concepts</article-title>
<source/>
<italic toggle="yes">Gut</italic>
<year>2008</year>
<volume>57</volume>
<issue>5</issue>
<fpage>684</fpage>
<lpage>694</lpage>
<pub-id pub-id-type="doi">10.1136/gut.2006.117382</pub-id>
<pub-id pub-id-type="other">2-s2.0-42549168550</pub-id>
<pub-id pub-id-type="pmid">18408105</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Circu</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Aw</surname>
<given-names>T. Y.</given-names>
</name>
</person-group>
<article-title>Reactive oxygen species, cellular redox systems, and apoptosis</article-title>
<source/>
<italic toggle="yes">Free Radical Biology and Medicine</italic>
<year>2010</year>
<volume>48</volume>
<issue>6</issue>
<fpage>749</fpage>
<lpage>762</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.12.022</pub-id>
<pub-id pub-id-type="other">2-s2.0-76049083966</pub-id>
<pub-id pub-id-type="pmid">20045723</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aw</surname>
<given-names>N. S. R.</given-names>
</name>
<name>
<surname>Seronello</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S. H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection</article-title>
<source/>
<italic toggle="yes">Hepatology</italic>
<year>2010</year>
<volume>52</volume>
<issue>1</issue>
<fpage>47</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1002/hep.23671</pub-id>
<pub-id pub-id-type="other">2-s2.0-77954236285</pub-id>
<pub-id pub-id-type="pmid">20578128</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Catarzi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Romagnoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Marcucci</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Favilli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Iantomasi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vincenzini</surname>
<given-names>M. T.</given-names>
</name>
</person-group>
<article-title>Redox regulation of ERK1/2 activation induced by sphingosine 1-phosphate in fibroblasts: involvement of NADPH oxidase and platelet-derived growth factor receptor</article-title>
<source/>
<italic toggle="yes">Biochimica et Biophysica Acta (BBA)-General Subjects</italic>
<year>2011</year>
<volume>1810</volume>
<issue>4</issue>
<fpage>446</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbagen.2011.01.005</pub-id>
<pub-id pub-id-type="other">2-s2.0-79751532260</pub-id>
<pub-id pub-id-type="pmid">21256191</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romagnoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Marcucci</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Favilli</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells</article-title>
<source/>
<italic toggle="yes">FEBS Journal</italic>
<year>2013</year>
<volume>280</volume>
<fpage>867</fpage>
<lpage>879</lpage>
<pub-id pub-id-type="doi">10.1111/febs.12075</pub-id>
<pub-id pub-id-type="other">2-s2.0-84873139186</pub-id>
<pub-id pub-id-type="pmid">23176170</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>D. P.</given-names>
</name>
</person-group>
<article-title>[11] redox potential of GSH/GSSG couple: assay and biological significance</article-title>
<source/>
<italic toggle="yes">Protein Sensors and Reactive Oxygen Species-Part B: Thiol Enzymes and Proteins</italic>
<year>2002</year>
<volume>348</volume>
<fpage>93</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1016/s0076-6879(02)48630-2</pub-id>
<pub-id pub-id-type="other">2-s2.0-0036372619</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romagnoli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Marcucci</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Picariello</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tonelli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Vincenzini</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Iantomasi</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Role of N-acetylcysteine and GSH redox system on total and active MMP-2 in intestinal myofibroblasts of Crohn’s disease patients</article-title>
<source/>
<italic toggle="yes">International Journal of Colorectal Disease</italic>
<year>2012</year>
<volume>28</volume>
<issue>7</issue>
<fpage>915</fpage>
<lpage>924</lpage>
<pub-id pub-id-type="doi">10.1007/s00384-012-1632-2</pub-id>
<pub-id pub-id-type="other">2-s2.0-84880752512</pub-id>
<pub-id pub-id-type="pmid">23271497</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iantomasi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Favilli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Catarzi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vincenzini</surname>
<given-names>M. T.</given-names>
</name>
</person-group>
<article-title>GSH role on platelet-derived growth factor receptor tyrosine phosphorylation induced by H<sub>2</sub>O<sub>2</sub></article-title>
<source/>
<italic toggle="yes">Biochemical and Biophysical Research Communications</italic>
<year>2001</year>
<volume>280</volume>
<issue>5</issue>
<fpage>1279</fpage>
<lpage>1285</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.2001.4274</pub-id>
<pub-id pub-id-type="other">2-s2.0-0034804566</pub-id>
<pub-id pub-id-type="pmid">11162667</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blanco</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>B. A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diurnal variation in glutathione and cysteine redox states in human plasma</article-title>
<source/>
<italic toggle="yes">American Journal of Clinical Nutrition</italic>
<year>2007</year>
<volume>86</volume>
<issue>4</issue>
<fpage>1016</fpage>
<lpage>1023</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/86.4.1016</pub-id>
<pub-id pub-id-type="pmid">17921379</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franco</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schoneveld</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>Pappa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Panayiotidis</surname>
<given-names>M. I.</given-names>
</name>
</person-group>
<article-title>The central role of glutathione in the pathophysiology of human diseases</article-title>
<source/>
<italic toggle="yes">Archives of Physiology and Biochemistry</italic>
<year>2008</year>
<volume>113</volume>
<issue>4-5</issue>
<fpage>234</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1080/13813450701661198</pub-id>
<pub-id pub-id-type="other">2-s2.0-37549023835</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Marcucci</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Iantomasi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Brandi</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Vincenzini</surname>
<given-names>M. T.</given-names>
</name>
</person-group>
<article-title>Glutathione, N-acetylcysteine and lipoic acid down-regulate starvation-induced apoptosis, RANKL/OPG ratio and sclerostin in osteocytes: involvement of JNK and ERK1/2 signalling</article-title>
<source/>
<italic toggle="yes">Calcified Tissue International</italic>
<year>2015</year>
<volume>96</volume>
<issue>4</issue>
<fpage>335</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="doi">10.1007/s00223-015-9961-0</pub-id>
<pub-id pub-id-type="other">2-s2.0-84925539822</pub-id>
<pub-id pub-id-type="pmid">25660312</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Pelton</surname>
<given-names>R.</given-names>
</name>
</person-group>
<source/>
<italic toggle="yes">Drug-Induced Nutrient Depletion Handbook</italic>
<year>2001</year>
<edition>2nd</edition>
<publisher-loc>Hudson, OH, USA</publisher-loc>
<publisher-name>Lexi-Comp’s Clinical Reference Library, Lexi-Comp</publisher-name>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>Y.-L.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X.-L.</given-names>
</name>
</person-group>
<article-title>Effect of glucocorticoid-induced oxidative stress on the expression of Cbfa1</article-title>
<source/>
<italic toggle="yes">Chemico-Biological Interactions</italic>
<year>2014</year>
<volume>207</volume>
<fpage>26</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.cbi.2013.11.004</pub-id>
<pub-id pub-id-type="other">2-s2.0-84888589730</pub-id>
<pub-id pub-id-type="pmid">24239970</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohn</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kern</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Saltzman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mitmesser</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McKay</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Evidence of drug-nutrient interactions with chronic use of commonly prescribed medications: an update</article-title>
<source/>
<italic toggle="yes">Pharmaceutics</italic>
<year>2018</year>
<volume>10</volume>
<issue>1</issue>
<fpage>36</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.3390/pharmaceutics10010036</pub-id>
<pub-id pub-id-type="other">2-s2.0-85044320543</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samaras</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Samaras</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>P.-O.</given-names>
</name>
<name>
<surname>Genton</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Frangos</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pichard</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Effects of widely used drugs on micronutrients: a story rarely told</article-title>
<source/>
<italic toggle="yes">Nutrition</italic>
<year>2013</year>
<volume>29</volume>
<issue>4</issue>
<fpage>605</fpage>
<lpage>610</lpage>
<pub-id pub-id-type="doi">10.1016/j.nut.2012.11.011</pub-id>
<pub-id pub-id-type="other">2-s2.0-84875328846</pub-id>
<pub-id pub-id-type="pmid">23466046</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russell</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The importance of patients’ nutritional status in wound healing</article-title>
<source/>
<italic toggle="yes">British Journal of Nursing</italic>
<year>2001</year>
<volume>10</volume>
<issue>6</issue>
<fpage>S42</fpage>
<lpage>S49</lpage>
<pub-id pub-id-type="doi">10.12968/bjon.2001.10.sup1.5336</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baek</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>K. W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>W. Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures</article-title>
<source/>
<italic toggle="yes">Calcified Tissue International</italic>
<year>2010</year>
<volume>87</volume>
<issue>3</issue>
<fpage>226</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="doi">10.1007/s00223-010-9393-9</pub-id>
<pub-id pub-id-type="other">2-s2.0-85027957985</pub-id>
<pub-id pub-id-type="pmid">20614110</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yousefzadeh</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Larijani</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mohammadirad</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Determination of oxidative stress status and concentration of TGF-<italic>β</italic>1 in the blood and saliva of osteoporotic subjects</article-title>
<source/>
<italic toggle="yes">Annals of the New York Academy of Sciences</italic>
<year>2006</year>
<volume>1091</volume>
<issue>1</issue>
<fpage>142</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1196/annals.1378.062</pub-id>
<pub-id pub-id-type="other">2-s2.0-33947600578</pub-id>
<pub-id pub-id-type="pmid">17341610</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lean</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Jagger</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Kirstein</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fuller</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>T. J.</given-names>
</name>
</person-group>
<article-title>Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation</article-title>
<source/>
<italic toggle="yes">Endocrinology</italic>
<year>2005</year>
<volume>146</volume>
<issue>2</issue>
<fpage>728</fpage>
<lpage>735</lpage>
<pub-id pub-id-type="doi">10.1210/en.2004-1021</pub-id>
<pub-id pub-id-type="other">2-s2.0-12344281693</pub-id>
<pub-id pub-id-type="pmid">15528306</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almeida</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Martin-Millan</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids</article-title>
<source/>
<italic toggle="yes">Journal of Biological Chemistry</italic>
<year>2007</year>
<volume>282</volume>
<issue>37</issue>
<fpage>27285</fpage>
<lpage>27297</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.m702810200</pub-id>
<pub-id pub-id-type="other">2-s2.0-34848878406</pub-id>
<pub-id pub-id-type="pmid">17623659</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krakauer</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Nuclear factor-κb: fine-tuning a central integrator of diverse biologic stimuli</article-title>
<source/>
<italic toggle="yes">International Reviews of Immunology</italic>
<year>2009</year>
<volume>27</volume>
<issue>5</issue>
<fpage>286</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="doi">10.1080/08830180802317957</pub-id>
<pub-id pub-id-type="other">2-s2.0-53949106937</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filaire</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Toumi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Reactive oxygen species and exercise on bone metabolism: friend or enemy?</article-title>
<source/>
<italic toggle="yes">Joint Bone Spine</italic>
<year>2012</year>
<volume>79</volume>
<issue>4</issue>
<fpage>341</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="doi">10.1016/j.jbspin.2012.03.007</pub-id>
<pub-id pub-id-type="other">2-s2.0-84863223036</pub-id>
<pub-id pub-id-type="pmid">22578961</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wijenayaka</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Kogawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>H. P.</given-names>
</name>
<name>
<surname>Bonewald</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Findlay</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Atkins</surname>
<given-names>G. J.</given-names>
</name>
</person-group>
<article-title>Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway</article-title>
<source/>
<italic toggle="yes">PLoS One</italic>
<year>2011</year>
<volume>6</volume>
<issue>10</issue>
<pub-id pub-id-type="publisher-id">e25900</pub-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0025900</pub-id>
<pub-id pub-id-type="other">2-s2.0-80053518269</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Wnt signaling in bone formation and its therapeutic potential for bone diseases</article-title>
<source/>
<italic toggle="yes">Therapeutic Advances in Musculoskeletal Disease</italic>
<year>2013</year>
<volume>5</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1177/1759720x12466608</pub-id>
<pub-id pub-id-type="other">2-s2.0-84878348235</pub-id>
<pub-id pub-id-type="pmid">23514963</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henriksen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Neutzsky-Wulff</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Bonewald</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Karsdal</surname>
<given-names>M. A.</given-names>
</name>
</person-group>
<article-title>Local communication on and within bone controls bone remodeling</article-title>
<source/>
<italic toggle="yes">Bone</italic>
<year>2009</year>
<volume>44</volume>
<issue>6</issue>
<fpage>1026</fpage>
<lpage>1033</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2009.03.671</pub-id>
<pub-id pub-id-type="other">2-s2.0-67349277390</pub-id>
<pub-id pub-id-type="pmid">19345750</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonewald</surname>
<given-names>L. F.</given-names>
</name>
</person-group>
<article-title>The amazing osteocyte</article-title>
<source/>
<italic toggle="yes">Journal of Bone and Mineral Research</italic>
<year>2011</year>
<volume>26</volume>
<issue>2</issue>
<fpage>229</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.320</pub-id>
<pub-id pub-id-type="other">2-s2.0-79251493453</pub-id>
<pub-id pub-id-type="pmid">21254230</pub-id>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wauquier</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Leotoing</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Coxam</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Guicheux</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wittrant</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Oxidative stress in bone remodelling and disease</article-title>
<source/>
<italic toggle="yes">Trends in Molecular Medicine</italic>
<year>2009</year>
<volume>15</volume>
<issue>10</issue>
<fpage>468</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2009.08.004</pub-id>
<pub-id pub-id-type="other">2-s2.0-70350105153</pub-id>
<pub-id pub-id-type="pmid">19811952</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jilka</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Noble</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Weinstein</surname>
<given-names>R. S.</given-names>
</name>
</person-group>
<article-title>Osteocyte apoptosis</article-title>
<source/>
<italic toggle="yes">Bone</italic>
<year>2013</year>
<volume>54</volume>
<issue>2</issue>
<fpage>264</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2012.11.038</pub-id>
<pub-id pub-id-type="other">2-s2.0-84875837939</pub-id>
<pub-id pub-id-type="pmid">23238124</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khamaisi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Regev</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yarom</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Possible association between diabetes and bisphosphonate-related jaw osteonecrosis</article-title>
<source/>
<italic toggle="yes">Journal of Clinical Endocrinology &amp; Metabolism</italic>
<year>2007</year>
<volume>92</volume>
<issue>3</issue>
<fpage>1172</fpage>
<lpage>1175</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2006-2036</pub-id>
<pub-id pub-id-type="other">2-s2.0-33947523729</pub-id>
<pub-id pub-id-type="pmid">17179196</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khosla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Burr</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cauley</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American society for bone and mineral research</article-title>
<source/>
<italic toggle="yes">Journal of Bone and Mineral Research</italic>
<year>2007</year>
<volume>22</volume>
<issue>10</issue>
<fpage>1479</fpage>
<lpage>1491</lpage>
<pub-id pub-id-type="doi">10.1359/jbmr.0707onj</pub-id>
<pub-id pub-id-type="other">2-s2.0-34848841461</pub-id>
<pub-id pub-id-type="pmid">17663640</pub-id>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dallner</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sindelar</surname>
<given-names>P. J.</given-names>
</name>
</person-group>
<article-title>Regulation of ubiquinone metabolism</article-title>
<source/>
<italic toggle="yes">Free Radical Biology and Medicine</italic>
<year>2000</year>
<volume>29</volume>
<issue>3‐4</issue>
<fpage>285</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1016/s0891-5849(00)00307-5</pub-id>
<pub-id pub-id-type="other">2-s2.0-0033796008</pub-id>
<pub-id pub-id-type="pmid">11035257</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brault</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Mantzoros</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Daskalopoulou</surname>
<given-names>S. S.</given-names>
</name>
</person-group>
<article-title>Statin treatment and new-onset diabetes: a review of proposed mechanisms</article-title>
<source/>
<italic toggle="yes">Metabolism</italic>
<year>2014</year>
<volume>63</volume>
<issue>6</issue>
<fpage>735</fpage>
<lpage>745</lpage>
<pub-id pub-id-type="doi">10.1016/j.metabol.2014.02.014</pub-id>
<pub-id pub-id-type="other">2-s2.0-84901200014</pub-id>
<pub-id pub-id-type="pmid">24641882</pub-id>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalyan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huebbe</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Esatbeyoglu</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Nitrogen-bisphosphonate therapy is linked to compromised coenzyme Q10 and vitamin E status in postmenopausal women</article-title>
<source/>
<italic toggle="yes">Journal of Clinical Endocrinology &amp; Metabolism</italic>
<year>2014</year>
<volume>99</volume>
<issue>4</issue>
<fpage>1307</fpage>
<lpage>1313</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2013-3648</pub-id>
<pub-id pub-id-type="other">2-s2.0-84898470109</pub-id>
<pub-id pub-id-type="pmid">24423355</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.-X.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>K.-J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Efficacy of coenzyme Q10 in mitigating spinal cord injury-induced osteoporosis</article-title>
<source/>
<italic toggle="yes">Molecular Medicine Reports</italic>
<year>2015</year>
<volume>12</volume>
<issue>3</issue>
<fpage>3909</fpage>
<lpage>3915</lpage>
<pub-id pub-id-type="doi">10.3892/mmr.2015.3856</pub-id>
<pub-id pub-id-type="other">2-s2.0-84935460695</pub-id>
<pub-id pub-id-type="pmid">26016719</pub-id>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jhun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Byun</surname>
<given-names>J.-K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Coenzyme Q10 suppresses Th17 cells and osteoclast differentiation and ameliorates experimental autoimmune arthritis mice</article-title>
<source/>
<italic toggle="yes">Immunology Letters</italic>
<year>2015</year>
<volume>166</volume>
<issue>2</issue>
<fpage>92</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1016/j.imlet.2015.05.012</pub-id>
<pub-id pub-id-type="other">2-s2.0-84936802351</pub-id>
<pub-id pub-id-type="pmid">26045320</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohanty</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hamouda</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Aljada</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ghanim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dandona</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes</article-title>
<source/>
<italic toggle="yes">Journal of Clinical Endocrinology &amp; Metabolism</italic>
<year>2000</year>
<volume>85</volume>
<issue>8</issue>
<fpage>2970</fpage>
<lpage>2973</lpage>
<pub-id pub-id-type="doi">10.1210/jc.85.8.2970</pub-id>
<pub-id pub-id-type="pmid">10946914</pub-id>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Hwa</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Aldose reductase, oxidative stress, and diabetes mellitus</article-title>
<source/>
<italic toggle="yes">Frontiers in Pharmacology</italic>
<year>2012</year>
<volume>3</volume>
<pub-id pub-id-type="doi">10.3389/fphar.2012.00087</pub-id>
<pub-id pub-id-type="other">2-s2.0-84863847452</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paravicini</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Touyz</surname>
<given-names>R. M.</given-names>
</name>
</person-group>
<article-title>NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities</article-title>
<source/>
<italic toggle="yes">Diabetes Care</italic>
<year>2008</year>
<volume>31</volume>
<issue>2</issue>
<fpage>S170</fpage>
<lpage>S180</lpage>
<pub-id pub-id-type="doi">10.2337/dc08-s247</pub-id>
<pub-id pub-id-type="pmid">18227481</pub-id>
</element-citation>
</ref>
<ref id="B41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Osborne</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>R. C.</given-names>
</name>
</person-group>
<article-title>Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex</article-title>
<source/>
<italic toggle="yes">American Journal of Physiology-Renal Physiology</italic>
<year>2005</year>
<volume>289</volume>
<issue>5</issue>
<fpage>F1040</fpage>
<lpage>F1047</lpage>
<pub-id pub-id-type="doi">10.1152/ajprenal.00076.2005</pub-id>
<pub-id pub-id-type="other">2-s2.0-26844519964</pub-id>
<pub-id pub-id-type="pmid">15956780</pub-id>
</element-citation>
</ref>
<ref id="B42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sen</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Redox signals in wound healing</article-title>
<source/>
<italic toggle="yes">Biochimica et Biophysica Acta (BBA)-General Subjects</italic>
<year>2008</year>
<volume>1780</volume>
<issue>11</issue>
<fpage>1348</fpage>
<lpage>1361</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbagen.2008.01.006</pub-id>
<pub-id pub-id-type="other">2-s2.0-49349108793</pub-id>
<pub-id pub-id-type="pmid">18249195</pub-id>
</element-citation>
</ref>
<ref id="B43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishimoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jutila</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Butcher</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>1989</year>
<volume>245</volume>
<issue>4923</issue>
<fpage>1238</fpage>
<lpage>1241</lpage>
<pub-id pub-id-type="doi">10.1126/science.2551036</pub-id>
<pub-id pub-id-type="other">2-s2.0-0024420563</pub-id>
<pub-id pub-id-type="pmid">2551036</pub-id>
</element-citation>
</ref>
<ref id="B44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponugoti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pacios</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Graves</surname>
<given-names>D. T.</given-names>
</name>
</person-group>
<article-title>FOXO1 promotes wound healing through the up-regulation of TGF-β1 and prevention of oxidative stress</article-title>
<source/>
<italic toggle="yes">Journal of Cell Biology</italic>
<year>2013</year>
<volume>203</volume>
<issue>2</issue>
<fpage>327</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.201305074</pub-id>
<pub-id pub-id-type="other">2-s2.0-84887512241</pub-id>
<pub-id pub-id-type="pmid">24145170</pub-id>
</element-citation>
</ref>
<ref id="B45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>James</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Swogger</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wolcott</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biofilms in chronic wounds</article-title>
<source/>
<italic toggle="yes">Wound Repair and Regeneration</italic>
<year>2007</year>
<volume>16</volume>
<issue>1</issue>
<fpage>37</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1111/j.1524-475x.2007.00321.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-38349111997</pub-id>
<pub-id pub-id-type="pmid">18086294</pub-id>
</element-citation>
</ref>
<ref id="B46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bjarnsholt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kirketerp-Møller</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>P. Ø.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Why chronic wounds will not heal: a novel hypothesis</article-title>
<source/>
<italic toggle="yes">Wound Repair and Regeneration</italic>
<year>2008</year>
<volume>16</volume>
<issue>1</issue>
<fpage>2</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1111/j.1524-475x.2007.00283.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-38349137064</pub-id>
<pub-id pub-id-type="pmid">18211573</pub-id>
</element-citation>
</ref>
<ref id="B47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gencer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cebeci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Irmak-Yazicioglu</surname>
<given-names>M. B.</given-names>
</name>
</person-group>
<article-title>Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines</article-title>
<source/>
<italic toggle="yes">Journal of Cancer Research</italic>
<year>2013</year>
<volume>25</volume>
<issue>3</issue>
<fpage>322</fpage>
<lpage>333</lpage>
</element-citation>
</ref>
<ref id="B48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valentin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bueb</surname>
<given-names>J.-L.</given-names>
</name>
<name>
<surname>Kieffer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tschirhart</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells</article-title>
<source/>
<italic toggle="yes">Fundamental and Clinical Pharmacology</italic>
<year>2005</year>
<volume>19</volume>
<issue>6</issue>
<fpage>661</fpage>
<lpage>667</lpage>
<pub-id pub-id-type="doi">10.1111/j.1472-8206.2005.00371.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-33645211800</pub-id>
<pub-id pub-id-type="pmid">16313278</pub-id>
</element-citation>
</ref>
<ref id="B49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhall</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Do</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Generating and reversing chronic wounds in diabetic mice by manipulating wound redox parameters</article-title>
<source/>
<italic toggle="yes">Journal of Diabetes Research</italic>
<year>2014</year>
<volume>2014</volume>
<fpage>18</fpage>
<pub-id pub-id-type="publisher-id">562625</pub-id>
<pub-id pub-id-type="doi">10.1155/2014/562625</pub-id>
<pub-id pub-id-type="other">2-s2.0-84920527789</pub-id>
</element-citation>
</ref>
<ref id="B50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christman</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Selvin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Margolis</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Lazarus</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Garza</surname>
<given-names>L. A.</given-names>
</name>
</person-group>
<article-title>Hemoglobin A1c predicts healing rate in diabetic wounds</article-title>
<source/>
<italic toggle="yes">Journal of Investigative Dermatology</italic>
<year>2011</year>
<volume>131</volume>
<issue>10</issue>
<fpage>2121</fpage>
<lpage>2127</lpage>
<pub-id pub-id-type="doi">10.1038/jid.2011.176</pub-id>
<pub-id pub-id-type="other">2-s2.0-80052848744</pub-id>
<pub-id pub-id-type="pmid">21697890</pub-id>
</element-citation>
</ref>
<ref id="B51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Afkhami-Ardekani</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Effect of vitamin c on blood glucose, serum lipids &amp; serum insulin in type 2 diabetic patients</article-title>
<source/>
<italic toggle="yes">Indian Journal of Medical Research</italic>
<year>2007</year>
<volume>126</volume>
<issue>5</issue>
<fpage>471</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="pmid">18160753</pub-id>
</element-citation>
</ref>
<ref id="B52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daisuke</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mizutani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impact of diabetes on gingival wound healing via oxidative stress</article-title>
<source/>
<italic toggle="yes">PLoS One</italic>
<year>2017</year>
<volume>12</volume>
<issue>12</issue>
<pub-id pub-id-type="publisher-id">e0189601</pub-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0189601</pub-id>
<pub-id pub-id-type="other">2-s2.0-85038889150</pub-id>
</element-citation>
</ref>
<ref id="B53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoneda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tomofuji</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kawabata</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Application of coenzyme Q10 for accelerating soft tissue wound healing after tooth extraction in rats</article-title>
<source/>
<italic toggle="yes">Nutrients</italic>
<year>2014</year>
<volume>6</volume>
<issue>12</issue>
<fpage>5756</fpage>
<lpage>5769</lpage>
<pub-id pub-id-type="doi">10.3390/nu6125756</pub-id>
<pub-id pub-id-type="other">2-s2.0-84916899013</pub-id>
<pub-id pub-id-type="pmid">25514392</pub-id>
</element-citation>
</ref>
<ref id="B54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vileikyte</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Leventhal</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Psychological aspects of diabetic neuropathic foot complications: an overview</article-title>
<source/>
<italic toggle="yes">Diabetes/Metabolism Research and Reviews</italic>
<year>2004</year>
<volume>20</volume>
<issue>S1</issue>
<fpage>S13</fpage>
<lpage>S18</lpage>
<pub-id pub-id-type="doi">10.1002/dmrr.437</pub-id>
</element-citation>
</ref>
<ref id="B55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGinnis</surname>
<given-names>W. R.</given-names>
</name>
</person-group>
<article-title>Oxidative stress in autism</article-title>
<source/>
<italic toggle="yes">Alternative Therapies in Health and Medicine</italic>
<year>2004</year>
<volume>10</volume>
<issue>6</issue>
<fpage>22</fpage>
<lpage>36</lpage>
</element-citation>
</ref>
<ref id="B56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeffcoate</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>The causes of the Charcot syndrome</article-title>
<source/>
<italic toggle="yes">Clinics in Podiatric Medicine and Surgery</italic>
<year>2008</year>
<volume>25</volume>
<issue>1</issue>
<fpage>29</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.cpm.2007.10.003</pub-id>
<pub-id pub-id-type="other">2-s2.0-37349092698</pub-id>
<pub-id pub-id-type="pmid">18165109</pub-id>
</element-citation>
</ref>
<ref id="B57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katayama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Akatsu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kugai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia</article-title>
<source/>
<italic toggle="yes">Journal of Bone and Mineral Research</italic>
<year>1996</year>
<volume>11</volume>
<issue>7</issue>
<fpage>931</fpage>
<lpage>937</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.5650110709</pub-id>
<pub-id pub-id-type="pmid">8797113</pub-id>
</element-citation>
</ref>
<ref id="B58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baynes</surname>
<given-names>J. W.</given-names>
</name>
</person-group>
<article-title>Role of oxidative stress in development of complications in diabetes</article-title>
<source/>
<italic toggle="yes">Diabetes</italic>
<year>1991</year>
<volume>40</volume>
<issue>4</issue>
<fpage>405</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.40.4.405</pub-id>
<pub-id pub-id-type="pmid">2010041</pub-id>
</element-citation>
</ref>
<ref id="B59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alikhani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alikhani</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Boyd</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways</article-title>
<source/>
<italic toggle="yes">Bone</italic>
<year>2007</year>
<volume>40</volume>
<issue>2</issue>
<fpage>345</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2006.09.011</pub-id>
<pub-id pub-id-type="other">2-s2.0-33846010477</pub-id>
<pub-id pub-id-type="pmid">17064973</pub-id>
</element-citation>
</ref>
<ref id="B60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franklin</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Wohleb</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fogaça</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hare</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Duman</surname>
<given-names>R. S.</given-names>
</name>
</person-group>
<article-title>Persistent increase in microglial RAGE contributes to chronic stress-induced priming of depressive-like behavior</article-title>
<source/>
<italic toggle="yes">Biological Psychiatry</italic>
<year>2018</year>
<volume>83</volume>
<issue>1</issue>
<fpage>50</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.06.034</pub-id>
<pub-id pub-id-type="other">2-s2.0-85028726277</pub-id>
<pub-id pub-id-type="pmid">28882317</pub-id>
</element-citation>
</ref>
<ref id="B61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anzilotti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Giampà</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Laurenti</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington’s disease</article-title>
<source/>
<italic toggle="yes">Brain Research Bulletin</italic>
<year>2012</year>
<volume>87</volume>
<issue>2–3</issue>
<fpage>350</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.01.009</pub-id>
<pub-id pub-id-type="other">2-s2.0-84856590656</pub-id>
<pub-id pub-id-type="pmid">21272617</pub-id>
</element-citation>
</ref>
<ref id="B62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yaturu</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Diabetes and skeletal health</article-title>
<source/>
<italic toggle="yes">Journal of Diabetes</italic>
<year>2009</year>
<volume>1</volume>
<issue>4</issue>
<fpage>246</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1111/j.1753-0407.2009.00049.x</pub-id>
<pub-id pub-id-type="pmid">20923525</pub-id>
</element-citation>
</ref>
<ref id="B63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soro-Paavonen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>A. M. D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes</article-title>
<source/>
<italic toggle="yes">Diabetes</italic>
<year>2008</year>
<volume>57</volume>
<issue>9</issue>
<fpage>2461</fpage>
<lpage>2469</lpage>
<pub-id pub-id-type="doi">10.2337/db07-1808</pub-id>
<pub-id pub-id-type="other">2-s2.0-52749084063</pub-id>
<pub-id pub-id-type="pmid">18511846</pub-id>
</element-citation>
</ref>
<ref id="B64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panizo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cardus</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Encinas</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway</article-title>
<source/>
<italic toggle="yes">Circulation Research</italic>
<year>2009</year>
<volume>104</volume>
<issue>9</issue>
<fpage>1041</fpage>
<lpage>1048</lpage>
<pub-id pub-id-type="doi">10.1161/circresaha.108.189001</pub-id>
<pub-id pub-id-type="other">2-s2.0-66149095438</pub-id>
<pub-id pub-id-type="pmid">19325147</pub-id>
</element-citation>
</ref>
<ref id="B65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steitz</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Speer</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Curinga</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Smooth muscle cell phenotypic transition associated with calcification</article-title>
<source/>
<italic toggle="yes">Circulation Research</italic>
<year>2001</year>
<volume>89</volume>
<issue>12</issue>
<fpage>1147</fpage>
<lpage>1154</lpage>
<pub-id pub-id-type="doi">10.1161/hh2401.101070</pub-id>
<pub-id pub-id-type="other">2-s2.0-0035824898</pub-id>
<pub-id pub-id-type="pmid">11739279</pub-id>
</element-citation>
</ref>
<ref id="B66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santavirta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Konttinen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nordstrom</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunologic studies of nonunited fractures</article-title>
<source/>
<italic toggle="yes">Acta Orthopaedica</italic>
<year>1992</year>
<volume>63</volume>
<issue>6</issue>
<fpage>579</fpage>
<lpage>586</lpage>
<pub-id pub-id-type="doi">10.3109/17453679209169713</pub-id>
</element-citation>
</ref>
<ref id="B67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrova</surname>
<given-names>N. L.</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>C. M.</given-names>
</name>
</person-group>
<article-title>Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy</article-title>
<source/>
<italic toggle="yes">Osteoporosis International</italic>
<year>2013</year>
<volume>25</volume>
<issue>4</issue>
<fpage>1197</fpage>
<lpage>1207</lpage>
<pub-id pub-id-type="doi">10.1007/s00198-013-2511-6</pub-id>
<pub-id pub-id-type="other">2-s2.0-84897876113</pub-id>
<pub-id pub-id-type="pmid">24091593</pub-id>
</element-citation>
</ref>
<ref id="B68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moon</surname>
<given-names>J.-S.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Beabout</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Swee</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Dyck</surname>
<given-names>P. J.</given-names>
</name>
</person-group>
<article-title>A controlled study of medial arterial calcification of legs</article-title>
<source/>
<italic toggle="yes">Archives of Neurology</italic>
<year>2011</year>
<volume>68</volume>
<issue>10</issue>
<fpage>1290</fpage>
<lpage>1294</lpage>
<pub-id pub-id-type="doi">10.1001/archneurol.2011.211</pub-id>
<pub-id pub-id-type="other">2-s2.0-84856392305</pub-id>
<pub-id pub-id-type="pmid">21987542</pub-id>
</element-citation>
</ref>
<ref id="B69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Niskanen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Suhonen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rönnemaa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Laakso</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Medial artery calcification</article-title>
<source/>
<italic toggle="yes">Arteriosclerosis, Thrombosis, and Vascular Biology</italic>
<year>1996</year>
<volume>16</volume>
<issue>8</issue>
<fpage>978</fpage>
<lpage>983</lpage>
<pub-id pub-id-type="doi">10.1161/01.atv.16.8.978</pub-id>
<pub-id pub-id-type="other">2-s2.0-0029817038</pub-id>
</element-citation>
</ref>
<ref id="B70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donath</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Shoelson</surname>
<given-names>S. E.</given-names>
</name>
</person-group>
<article-title>Type 2 diabetes as an inflammatory disease</article-title>
<source/>
<italic toggle="yes">Nature Reviews Immunology</italic>
<year>2011</year>
<volume>11</volume>
<issue>2</issue>
<fpage>98</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1038/nri2925</pub-id>
<pub-id pub-id-type="other">2-s2.0-79151478555</pub-id>
</element-citation>
</ref>
<ref id="B71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edmonds</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dew</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Musto</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum proinflammatory cytokines TNF-alpha and IL-6 are raised in acute Charcot osteoarthropathy and correlate with a marker of bone resorption</article-title>
<source/>
<italic toggle="yes">Diabetologia</italic>
<year>2008</year>
<volume>51</volume>
<issue>1</issue>
<fpage>p. S510</fpage>
</element-citation>
</ref>
<ref id="B72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satoh</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yagihashi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Toyota</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>The possible role of tumor necrosis factor-<italic>α</italic> in diabetic polyneuropathy</article-title>
<source/>
<italic toggle="yes">Experimental Diabesity Research</italic>
<year>2003</year>
<volume>4</volume>
<issue>2</issue>
<fpage>65</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1155/edr.2003.65</pub-id>
<pub-id pub-id-type="other">2-s2.0-0042828892</pub-id>
<pub-id pub-id-type="pmid">14630568</pub-id>
</element-citation>
</ref>
<ref id="B73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomsen</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Rathcke</surname>
<given-names>C. N.</given-names>
</name>
<name>
<surname>Zerahn</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Vestergaard</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Increased levels of the calcification marker matrix Gla protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease</article-title>
<source/>
<italic toggle="yes">Cardiovascular Diabetology</italic>
<year>2010</year>
<volume>9</volume>
<issue>1</issue>
<fpage>p. 86</fpage>
<pub-id pub-id-type="doi">10.1186/1475-2840-9-86</pub-id>
<pub-id pub-id-type="other">2-s2.0-78649789498</pub-id>
<pub-id pub-id-type="pmid">21143859</pub-id>
</element-citation>
</ref>
<ref id="B74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopes-Virella</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>N. L.</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>K. J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes</article-title>
<source/>
<italic toggle="yes">Atherosclerosis</italic>
<year>2011</year>
<volume>214</volume>
<issue>2</issue>
<fpage>462</fpage>
<lpage>467</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2010.11.012</pub-id>
<pub-id pub-id-type="other">2-s2.0-79151476184</pub-id>
<pub-id pub-id-type="pmid">21156319</pub-id>
</element-citation>
</ref>
<ref id="B75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uttara</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zamboni</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mahajan</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options</article-title>
<source/>
<italic toggle="yes">Current Neuropharmacology</italic>
<year>2009</year>
<volume>7</volume>
<issue>1</issue>
<fpage>65</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.2174/157015909787602823</pub-id>
<pub-id pub-id-type="other">2-s2.0-65949121134</pub-id>
<pub-id pub-id-type="pmid">19721819</pub-id>
</element-citation>
</ref>
<ref id="B76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brodeur</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Bouvet</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bouchard</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes</article-title>
<source/>
<italic toggle="yes">PLoS One</italic>
<year>2014</year>
<volume>9</volume>
<issue>1</issue>
<pub-id pub-id-type="publisher-id">e85922</pub-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0085922</pub-id>
<pub-id pub-id-type="other">2-s2.0-84908192097</pub-id>
</element-citation>
</ref>
<ref id="B77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.-J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>
<italic>α</italic>-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway</article-title>
<source/>
<italic toggle="yes">Journal of Cellular and Molecular Medicine</italic>
<year>2012</year>
<volume>16</volume>
<issue>2</issue>
<fpage>273</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="doi">10.1111/j.1582-4934.2011.01294.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-84863013823</pub-id>
<pub-id pub-id-type="pmid">21362131</pub-id>
</element-citation>
</ref>
<ref id="B78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yoshihara</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vitamin D switches BAF complexes to protect β cells</article-title>
<source/>
<italic toggle="yes">Cell</italic>
<year>2018</year>
<volume>173</volume>
<issue>5</issue>
<fpage>1135</fpage>
<lpage>1149</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2018.04.013</pub-id>
<pub-id pub-id-type="other">2-s2.0-85046697155</pub-id>
<pub-id pub-id-type="pmid">29754817</pub-id>
</element-citation>
</ref>
<ref id="B79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akhavani</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Sivakumar</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Paleolog</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Angiogenesis and plastic surgery</article-title>
<source/>
<italic toggle="yes">Journal of Plastic, Reconstructive &amp; Aesthetic Surgery</italic>
<year>2008</year>
<volume>61</volume>
<issue>12</issue>
<fpage>1425</fpage>
<lpage>1437</lpage>
<pub-id pub-id-type="doi">10.1016/j.bjps.2008.05.041</pub-id>
<pub-id pub-id-type="other">2-s2.0-55249109354</pub-id>
</element-citation>
</ref>
<ref id="B80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q. F.</given-names>
</name>
</person-group>
<article-title>Improvement of the skin flap survival with the bone marrow-derived mononuclear cells transplantation in a rat model</article-title>
<source/>
<italic toggle="yes">Microsurgery</italic>
<year>2010</year>
<volume>30</volume>
<fpage>275</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="doi">10.1002/micr.20779</pub-id>
<pub-id pub-id-type="other">2-s2.0-77952999265</pub-id>
<pub-id pub-id-type="pmid">20309852</pub-id>
</element-citation>
</ref>
<ref id="B81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>K. C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Anti-inflammatory effects of anthocyanins from black soybean seed coat on the keratinocytes and ischemia-reperfusion injury in rat skin flaps</article-title>
<source/>
<italic toggle="yes">Microsurgery</italic>
<year>2012</year>
<volume>32</volume>
<issue>7</issue>
<fpage>563</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="doi">10.1002/micr.22019</pub-id>
<pub-id pub-id-type="other">2-s2.0-84867552575</pub-id>
<pub-id pub-id-type="pmid">22821773</pub-id>
</element-citation>
</ref>
<ref id="B82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angel</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Narayanan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Swartz</surname>
<given-names>W. M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deferoxamine increases skin flap survival: additional evidence of free radical involvement in ischaemic flap surgery</article-title>
<source/>
<italic toggle="yes">British Journal of Plastic Surgery</italic>
<year>1986</year>
<volume>39</volume>
<issue>4</issue>
<fpage>469</fpage>
<lpage>472</lpage>
<pub-id pub-id-type="doi">10.1016/0007-1226(86)90115-3</pub-id>
<pub-id pub-id-type="other">2-s2.0-0023038849</pub-id>
<pub-id pub-id-type="pmid">3779193</pub-id>
</element-citation>
</ref>
<ref id="B83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mascotti</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Rup</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Thach</surname>
<given-names>R. E.</given-names>
</name>
</person-group>
<article-title>Regulation of iron metabolism: translational effects medicated by iron, heme, and cytokines</article-title>
<source/>
<italic toggle="yes">Annual Review of Nutrition</italic>
<year>1995</year>
<volume>15</volume>
<issue>1</issue>
<fpage>239</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.nutr.15.1.239</pub-id>
</element-citation>
</ref>
<ref id="B84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Im</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Manson</surname>
<given-names>P. N.</given-names>
</name>
<name>
<surname>Bulkley</surname>
<given-names>G. B.</given-names>
</name>
<name>
<surname>Hoopes</surname>
<given-names>J. E.</given-names>
</name>
</person-group>
<article-title>Effects of superoxide dismutase and allopurinol on the survival of acute island skin flaps</article-title>
<source/>
<italic toggle="yes">Annals of Surgery</italic>
<year>1985</year>
<volume>201</volume>
<issue>3</issue>
<fpage>357</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="doi">10.1097/00000658-198503000-00018</pub-id>
<pub-id pub-id-type="other">2-s2.0-0021885680</pub-id>
<pub-id pub-id-type="pmid">3977440</pub-id>
</element-citation>
</ref>
<ref id="B85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Iwaguchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shudo</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Change in tissue concentrations of lipid hydroperoxides, vitamin C and vitamin E in rats with streptozotocin-induced diabetes</article-title>
<source/>
<italic toggle="yes">Clinical Science</italic>
<year>1999</year>
<volume>96</volume>
<issue>2</issue>
<fpage>185</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1042/cs19980189</pub-id>
<pub-id pub-id-type="pmid">9918899</pub-id>
</element-citation>
</ref>
<ref id="B86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thornalley</surname>
<given-names>P. J.</given-names>
</name>
</person-group>
<article-title>Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts</article-title>
<source/>
<italic toggle="yes">Archives of Biochemistry and Biophysics</italic>
<year>2003</year>
<volume>419</volume>
<issue>1</issue>
<fpage>31</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/j.abb.2003.08.013</pub-id>
<pub-id pub-id-type="other">2-s2.0-0142074864</pub-id>
<pub-id pub-id-type="pmid">14568006</pub-id>
</element-citation>
</ref>
<ref id="B87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maiorino</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Bellastella</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Diabetes and sexual dysfunction: current perspectives</article-title>
<source/>
<italic toggle="yes">Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy</italic>
<year>2014</year>
<volume>7</volume>
<fpage>95</fpage>
<lpage>105</lpage>
</element-citation>
</ref>
<ref id="B88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Redrow</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Treatment strategies for diabetic patients suffering from erectile dysfunction: an update</article-title>
<source/>
<italic toggle="yes">Expert opinion on pharmacotherapy</italic>
<year>2014</year>
<volume>15</volume>
<issue>13</issue>
<fpage>1827</fpage>
<lpage>1836</lpage>
<pub-id pub-id-type="doi">10.1517/14656566.2014.934809</pub-id>
<pub-id pub-id-type="other">2-s2.0-84905821185</pub-id>
<pub-id pub-id-type="pmid">24976035</pub-id>
</element-citation>
</ref>
<ref id="B89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Radisavljevic</surname>
<given-names>Z. M.</given-names>
</name>
<name>
<surname>Siroky</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Azadzoi</surname>
<given-names>K. M.</given-names>
</name>
</person-group>
<article-title>Dietary antioxidants improve arteriogenic erectile dysfunction</article-title>
<source/>
<italic toggle="yes">International Journal of Andrology</italic>
<year>2010</year>
<volume>34</volume>
<issue>3</issue>
<fpage>225</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2605.2010.01083.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-79955579571</pub-id>
</element-citation>
</ref>
<ref id="B90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>N-acetylcysteine ameliorates the erectile dysfunction caused by chronic intermittent hypoxia in rats: partly involvement of endoplasmic reticulum stress</article-title>
<source/>
<italic toggle="yes">Urology</italic>
<year>2015</year>
<volume>86</volume>
<issue>4</issue>
<fpage>e7</fpage>
<lpage>e14</lpage>
<pub-id pub-id-type="doi">10.1016/j.urology.2015.07.013</pub-id>
<pub-id pub-id-type="other">2-s2.0-84942925315</pub-id>
<pub-id pub-id-type="pmid">26165617</pub-id>
</element-citation>
</ref>
<ref id="B91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>K.-L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>D.-S.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>X.-Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.-Z.</given-names>
</name>
</person-group>
<article-title>Effects of calcitriol on random skin flap survival in rats</article-title>
<source/>
<italic toggle="yes">Scientific Reports</italic>
<year>2016</year>
<volume>6</volume>
<issue>1</issue>
<fpage>p. 8945</fpage>
<pub-id pub-id-type="doi">10.1038/srep18945</pub-id>
<pub-id pub-id-type="other">2-s2.0-84954479004</pub-id>
</element-citation>
</ref>
<ref id="B92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ufuk</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Tuncer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kabakas</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effect of short- versus long-term administration of alpha tocopherol on the survival of random flaps in experimental diabetes mellitus</article-title>
<source/>
<italic toggle="yes">Journal of Diabetes and its Complications</italic>
<year>2004</year>
<volume>18</volume>
<issue>5</issue>
<fpage>249</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1016/j.jdiacomp.2004.05.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-4444382806</pub-id>
<pub-id pub-id-type="pmid">15337497</pub-id>
</element-citation>
</ref>
<ref id="B93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozturk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fırat</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Parlakpınar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bay-Karabulut</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kirimlioglu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gurlek</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Beneficial effects of aminoguanidine on skin flap survival in diabetic rats</article-title>
<source/>
<italic toggle="yes">Experimental Diabetes Research</italic>
<year>2012</year>
<volume>2012</volume>
<fpage>8</fpage>
<pub-id pub-id-type="publisher-id">721256</pub-id>
<pub-id pub-id-type="doi">10.1155/2012/721256</pub-id>
<pub-id pub-id-type="other">2-s2.0-84872153474</pub-id>
</element-citation>
</ref>
<ref id="B94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bozkurt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kapi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kulahci</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Antioxidant support in composite musculo-adipose-fasciocutaneous flap applications: an experimental study</article-title>
<source/>
<italic toggle="yes">Journal of Plastic Surgery and Hand Surgery</italic>
<year>2013</year>
<volume>48</volume>
<issue>1</issue>
<fpage>44</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.3109/2000656x.2013.800527</pub-id>
<pub-id pub-id-type="other">2-s2.0-84892631121</pub-id>
<pub-id pub-id-type="pmid">23731129</pub-id>
</element-citation>
</ref>
<ref id="B95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>Q.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Naringin improves random skin flap survival in rats</article-title>
<source/>
<italic toggle="yes">Oncotarget</italic>
<year>2017</year>
<volume>8</volume>
<issue>55</issue>
<fpage>94142</fpage>
<lpage>94150</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.21589</pub-id>
<pub-id pub-id-type="other">2-s2.0-85032932240</pub-id>
<pub-id pub-id-type="pmid">29212216</pub-id>
</element-citation>
</ref>
<ref id="B96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Temel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dokuyucu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mutaf</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The effect of coenzyme Q10 (ubiquinone) on random pattern skin flap survival in rat model</article-title>
<source/>
<italic toggle="yes">Annals of Plastic Surgery</italic>
<year>2016</year>
<volume>77</volume>
<issue>2</issue>
<fpage>e9</fpage>
<lpage>e14</lpage>
<pub-id pub-id-type="doi">10.1097/sap.0000000000000504</pub-id>
<pub-id pub-id-type="other">2-s2.0-84979520750</pub-id>
<pub-id pub-id-type="pmid">25954836</pub-id>
</element-citation>
</ref>
<ref id="B97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liakopoulos</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Roumeliotis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gorny</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Dounousi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>P. R.</given-names>
</name>
</person-group>
<article-title>Oxidative stress in hemodialysis patients: a review of the literature</article-title>
<source/>
<italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic>
<year>2017</year>
<volume>2017</volume>
<fpage>22</fpage>
<pub-id pub-id-type="publisher-id">3081856</pub-id>
<pub-id pub-id-type="doi">10.1155/2017/3081856</pub-id>
<pub-id pub-id-type="other">2-s2.0-85030629825</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="fig1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Metabolic fates of glucose relevant to the current focus.</p>
</caption>
<graphic xlink:href="JNME2018-4183407.001"></graphic>
</fig>
<table-wrap id="tab1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<p>Effects of prescription and over-the-counter medications on micronutrient levels in patients, including vitamins, minerals, and antioxidants ([<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>] and references in each).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Drug class</th>
<th align="center" colspan="1" rowspan="1">Nutrients depleted</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="2" rowspan="1">
<italic>Prescription medications</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Antibiotics (fluoroquinolones): Levaquin, Avelox, Cipro, Floxin, Noroxin, Penetrex, Trovan</td>
<td align="center" colspan="1" rowspan="1">Biotin, B1, B2, B3, B6, B12, zinc, and healthy intestinal bacteria</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Antibiotics (macrolides): erythromycin, azithromycin, Biaxin, Zithromax</td>
<td align="center" colspan="1" rowspan="1">Healthy intestinal bacteria, B1, B2, B3, B6, and B12</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Antibiotics (penicillins): amoxicillin, Amoxil, Trimox, penicillin</td>
<td align="center" colspan="1" rowspan="1">Healthy intestinal bacteria, B1, B2, B3, B6, B12, vitamin k, folic acid, biotin, and inositol</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ACE inhibitors: lisinopril, Altace, Accupril, Capoten, Prinivil, Zestril, Vasotec</td>
<td align="center" colspan="1" rowspan="1">Zinc</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Beta-2 adrenergic receptor agonists: albuterol aerosol, Brethine, Proventil, Tornalate, Ventolin, Xopenex</td>
<td align="center" colspan="1" rowspan="1">Potassium and possibly calcium-magnesium and phosphorus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Beta-blockers: atenolol, Corgard, Lopressor, Tenormin, Toprol XL, metoprolol</td>
<td align="center" colspan="1" rowspan="1">Coenzyme Q10, chromium, and melatonin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Biguanides: metformin, Glucophage</td>
<td align="center" colspan="1" rowspan="1">Folic acid, B12</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Bisphosphonates: Fosamax, Actonel, Boniva, Didronel, Skelid</td>
<td align="center" colspan="1" rowspan="1">Calcium-magnesium and phosphorus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Calcium channel blockers: amlodipine, felodipine, nifedipine, nimodipine, nisoldipine</td>
<td align="center" colspan="1" rowspan="1">Vitamin D</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cardiac glycosides: digoxin, Digitek, Lanoxin, Lanoxicaps</td>
<td align="center" colspan="1" rowspan="1">Calcium-magnesium, phosphorus, potassium, and B1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Conjugated estrogens: Premarin hormone replacement therapy, birth control pills</td>
<td align="center" colspan="1" rowspan="1">B6, vitamin D, calcium-magnesium, zinc, folic acid, and B12</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Corticosteroids: Flonase, Beclovent, Beconase, QVar, Vancenase, Vanceril, prednisone, Deltasone, Celestone, Cortisone, Cortef, Cortone, dexamethasone, Decadron, Hydrocortone, Medrol, methylprednisolone</td>
<td align="center" colspan="1" rowspan="1">Beta-carotene, B6, folic acid, vitamin C, vitamin D, calcium-magnesium, potassium, selenium, zinc, and melatonin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Loop diuretics: furosemide, Lasix, ethacrynic acid, Edecrin, Bumex</td>
<td align="center" colspan="1" rowspan="1">B1, B6, vitamin C, calcium-magnesium, phosphorus, potassium, and zinc</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Opiates: hydrocodone/acetaminophen, oxycodone</td>
<td align="center" colspan="1" rowspan="1">Folic acid, vitamin C, iron, and potassium</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Potassium sparing diuretics: amiloride, spironolactone, triamterene, aldactone, dyazide, Dyrenium, Maxzide</td>
<td align="center" colspan="1" rowspan="1">Calcium, magnesium, and phosphorus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Proton pump inhibitors: omeprazole, Prilosec, Prevacid, Nexium, Protonix, Aciphex</td>
<td align="center" colspan="1" rowspan="1">Beta-carotene, B1, B12, folic acid, calcium, and zinc</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Statins: Lipitor, Crestor, Lescol, Pravachol, Zocor, Mevacor</td>
<td align="center" colspan="1" rowspan="1">Coenzyme Q10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sulfonylurea: glyburide, glipizide, glimepiride, Amaryl, Diabeta, Glucotrol, Glynase, Micronase</td>
<td align="center" colspan="1" rowspan="1">Coenzyme Q10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Thiazide diuretics: hydrochlorothiazide</td>
<td align="center" colspan="1" rowspan="1">Vitamin D, calcium-magnesium, phosphorus, potassium, zinc, and coenzyme Q10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tricyclic antidepressants: Amitriptyline, clomipramine, doxepin, imipramine, Anafranil, Asendin, Elavil, Tofranil, Vivactil</td>
<td align="center" colspan="1" rowspan="1">Coenzyme Q10, B2, and sodium</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">
<italic>Over-the-counter medications</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Acetaminophen: Tylenol</td>
<td align="center" colspan="1" rowspan="1">Coenzyme Q10 and glutathione</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Antacids: Amphojel, Basaljel, aluminum hydroxide plus magnesium, Gaviscon, Gelusil, Maalox, Mylanta</td>
<td align="center" colspan="1" rowspan="1">Beta-carotene, folic acid, vitamin D, calcium-magnesium, chromium, iron, zinc, and phosphorus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Aspirin</td>
<td align="center" colspan="1" rowspan="1">Folic acid, vitamin C, iron, potassium, and zinc</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Laxatives with bisacodyl: Carter's little pills, Correctol, Dulcolax, Feen-A-Mint, PMS-Bisacodyl</td>
<td align="center" colspan="1" rowspan="1">Calcium and potassium</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NSAIDs: ibuprofen, naproxen</td>
<td align="center" colspan="1" rowspan="1">Folic acid</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">OTC proton-pump inhibitors: famotidine, pepcid, Tagamet, Zantac</td>
<td align="center" colspan="1" rowspan="1">Folic acid, B1, B12, vitamin D, calcium, iron, and zinc</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>